newsfilter
← Latest News
PR Newswire·

BiondVax announces financial plans to support its ongoing NanoAb pipeline development

JERUSALEM, Israel , Sept. 30, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) ("BiondVax"), a biotechnology company focused on developing, manufacturing, and commercializing innovative products for the prevention and treatment of infect